Welcome to the World Federation of ADHD
In August 2008, the World Federation of ADHD (Attention Deficit Hyperactivity Disorder) and allied disorders was founded in Zurich, Switzerland. Professor Andreas Warnke, Director of the Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy at the University of Würzburg, Germany, was officially nominated the first president of this non-profit organisation. Read more about the society
ADHD is a highly heritable childhood-onset psychiatric condition, which is characterized by age-inappropriate levels of the core symptoms inattention, hyperactivity and impulsivity. The disorder affects about 5 % of the children worldwide. Recent scientific studies in ADHD reveal biological underpinnings such as multiple genetic factors, ADHD-related differences in brain structure and function, as well as changes in neurotransmitter components within the basal ganglia thalamocortical neurocircuitries. Read more about ADHD
02 May 2016
ADHD Abstracts Review – May issue online now:
Highlighted abstracts of the month:
Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder (ADHD) and Substance Use During Adolescence: A Multi-Cohort National Study
Sean Esteban McCabe, Kara Dickinson, Brady T. West, Timothy E. Wilens
Journal of the American Academy of Child & Adolescent Psychiatry
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.
Notzon DP, Pavlicova M, Glass A, Mariani JJ, Mahony AL, Brooks DJ, Levin FR.
J Atten Disord. 2016 Mar 31. pii: 1087054716640109. [Epub ahead of print]